Yew Bio-Pharm Group, Inc. Research and Development Expense
Yew Bio-Pharm Group, Inc. reported Research and Development Expense of $0 for the 12-month period ending 2019-12-31, per its 10-K filed 2020-05-14.
Discontinued › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2020-05-14
- Yew Bio-Pharm Group, Inc. research and development expense for fiscal 2019 was $0.00.
- Yew Bio-Pharm Group, Inc. research and development expense for fiscal 2018 was $0.00.
- Yew Bio-Pharm Group, Inc. research and development expense for fiscal 2017 was $0.00, a 100.00% decline from fiscal 2016.
- Yew Bio-Pharm Group, Inc. research and development expense for fiscal 2016 was $860.00, a 93.66% decline from fiscal 2015.
| Period end | Research and Development Expense 12 month |
|---|---|
| 2019-12-31 | $0.00 10-K · filed 2020-05-14 |
| 2018-12-31 | $0.00 10-K · filed 2020-05-14 |
| 2017-12-31 | $0.00 10-K · filed 2019-05-07 |
| 2016-12-31 | $860.00 10-K · filed 2018-04-02 |
| 2015-12-31 | $13.55K 10-K · filed 2017-03-31 |
| 2014-12-31 | $53.54K 10-K · filed 2016-03-30 |
| 2013-12-31 | $23.13K 10-K · filed 2015-03-31 |
| 2012-12-31 | $14.59K 10-K · filed 2014-03-31 |
| 2011-12-31 | $16.05K 10-K · filed 2013-04-11 |